Abstract:Background: Crystal structures of the tobacco mosaic virus (TMV) coat protein (CP) in its helical and disk conformations have previously been determined at the atomic level. For the helical structure, interactions of proteins and nucleic acids in the main chains were clearly observed; however, the conformation of residues at the C-terminus was flexible and disordered. For the four-layer aggregate disk structure, interactions of the main chain residues could only be observed through water-mediated hydrogen bonding with protein residues. In this study, the effects of the C-terminal peptides on the interactions of TMV CP were investigated by crystal structure determination.Methodology/Principal Findings: The crystal structure of a genetically engineered TMV CP was resolved at 3.06 angstrom. For the genetically engineered TMV CP, a six-histidine (His) tag was introduced at the N-terminus, and the C-terminal residues 155 to 158 were truncated (N-His-TMV CP19). Overall, N-His-TMV CP19 protein self-assembled into the four-layer aggregate form. The conformations of residues Gln36, Thr59, Asp115 and Arg134 were carefully analyzed in the high radius and low radius regions of N-His-TMV CP19, which were found to be significantly different from those observed previously for the helical and four-layer aggregate forms. In addition, the aggregation of the N-His-TMV CP19 layers was found to primarily be mediated through direct hydrogen-bonding. Notably, this engineered protein also can package RNA effectively and assemble into an infectious virus particle.Conclusion: The terminal sequence of amino acids influences the conformation and interactions of the four-layer aggregate. Direct protein-protein interactions are observed in the major overlap region when residues Gly155 to Thr158 at the C-terminus are truncated. This engineered TMV CP is reassembled by direct protein-protein interaction and maintains the normal function of the four-layer aggregate of TMV CP in the presence of RNA.

Solution Structures of Engineered Vault Particles

Structure of Vault Purified from Rat Liver

The Structure of Rat Liver Vault at 3.5 Angstrom Resolution

Structural Insights into the Roles of PARP4 and NAD in the Human Vault Cage

The Vault Nanoparticle: A Gigantic Ribonucleoprotein Assembly Involved in Diverse Physiological and Pathological Phenomena and an Ideal Nanovector for Drug Delivery and Therapy

Crystal Structure Of A Four-Layer Aggregate Of Engineered Tmv Cp Implies The Importance Of Terminal Residues For Oligomer Assembly

Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer

Construct Design, Biophysical, and Biochemical Characterization of the Fusion Core from Mouse Hepatitis Virus (a Coronavirus) Spike Protein

Atomic model of vesicular stomatitis virus and mechanism of assembly

The structure and flexibility of conical HIV-1 capsids determined within intact virions

Structure of a viral procapsid with molecular scaffolding

Molecular Architecture of the Uncleaved HIV-1 Envelope Glycoprotein Trimer

Latest Advances in the Development of Eukaryotic Vaults as Targeted Drug Delivery Systems

Functional Anatomy of the Trimer Apex Reveals Key Hydrophobic Constraints That Maintain the HIV-1 Envelope Spike in a Closed State

Structural studies of the nucleus-like assembly of jumbo bacteriophage 201φ2-1

Crystallization and preliminary X-ray diffraction analysis of central structure domains from mumps virus F protein.

Structural Studies of Synthetic Peptide Fragments Derived from the Hiv-1 Vpr Protein

The crystal structure of vaccinia virus protein E2 and perspectives on the prediction of novel viral protein folds

An Ultrastable Virus‐Like Particle with a Carbon Dot Core and Expanded Sequence Plasticity

Structural Model of Bacteriophage P22 Scaffolding Protein in a Procapsid by Magic-Angle Spinning NMR

Structural insights into the conformational plasticity of the full-length trimeric HIV-1 envelope glycoprotein precursor